Co-infection of Toxoplasma gondii with other pathogens: pathogenicity and chemotherapy in animal models.
Lacroix
C
C
INSERM Unité 13, Hôpital Bichat-Claude Bernard, Paris, France.
Brun-Pascaud
M
M
Maslo
C
C
Chau
F
F
Romand
S
S
Derouin
F
F
D000818:Animals; D002415:Cats; D003587:Cytomegalovirus / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000628:therapy; D016089:Immunodeficiency Virus, Feline / Q000472:pathogenicity*; D016180:Lentivirus Infections / Q000150:complications / Q000628:therapy; D051379:Mice; D009162:Mycobacterium avium / Q000472:pathogenicity*; D009894:Opportunistic Infections / Q000150:complications / Q000628:therapy; D016720:Pneumocystis Infections / Q000150:complications / Q000628:therapy; D014122:Toxoplasma / Q000472:pathogenicity*; D014124:Toxoplasmosis, Animal / Q000150:complications / Q000628:therapy; D014376:Tuberculosis / Q000150:complications / Q000628:therapy; D014774:Virulence